The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

A major revision to the schedule for COVID-19 vaccines comes on the heels of Sen. Ron Johnson’s, R-Wis., issuance of an ...

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

The Trump administration is waging war against mRNA vaccines despite President Donald Trump having called them the “gold standard” when his admin rolled out the COVID shots […] ...

In another controversial move, Health and Human Services Secretary Robert F. Kennedy Jr. has abruptly fired all 17 members of ...

“Despite nearly four decades of effort by the global research community, an effective vaccine to prevent HIV remains an ...